Plasmodium falciparum is the causative agent of malaria, a disease where new drug targets are required due to increasing resistance to current anti-malarials. TMPK (thymidylate kinase) is a good candidate as it is essential for the synthesis of dTTP, a critical precursor of DNA and has been much studied due to its role in prodrug activation and as a drug target. Type I TMPKs, such as the human enzyme, phosphorylate the substrate AZT (3 -azido-3 -deoxythymidine)-MP (monophosphate) inefficiently compared with type II TMPKs (e.g. Escherichia coli TMPK). In the present paper we report that eukaryotic Pf TMPK (P. falciparum TMPK) presents sequence features of a type I enzyme yet the kinetic parameters for AZT-MP phosphorylation are similar to those of the highly efficient E. coli enzyme. Structural information shows that this is explained by a different juxtaposition of the P-loop and the azide of AZT-MP. Subsequent formation of the transition state requires no further movement of the Pf TMPK P-loop, with no steric conflicts for the azide moiety, allowing efficient phosphate transfer. Likewise, we present results that confirm the ability of the enzyme to uniquely accept dGMP as a substrate and shed light on the basis for its wider substrate specificity. Information resulting from two ternary complexes (dTMP-ADP and AZT-MP-ADP) and a binary complex with the transition state analogue AP 5 dT [P 1 -(5 -adenosyl)-P 5 -(5 -thymidyl) pentaphosphate] all reveal significant differences with the human enzyme, notably in the lid region and in the P-loop which may be exploited in the rational design of Plasmodiumspecific TMPK inhibitors with therapeutic potential.
INTRODUCTION
An essential step in the biosynthesis of the nucleotide dTTP is the phosphorylation of dTMP to dTDP. This reaction is catalysed by TMPK (thymidylate kinase; EC 2.7.4.9) in a magnesiumdependent manner with ATP as the preferred phosphate donor. Cellular production of dTTP is a highly regulated process [1, 2] , which is co-ordinated with DNA replication in the cell cycle, and TMPK has a central role in the control of the dTTP pool size in eukaryotic cells. The enzyme has been widely studied partly due to its participation in the pathway that leads to the activation of a number of prodrugs, including AZT (3 -azido-3 -deoxythymidine) and acyclovir for the treatment of AIDS and herpes simplex virus infections respectively [3, 4] . TMPK is also being investigated as a drug target in its own right and specific inhibitors of the orthologous enzymes from Bacillus anthracis and Mycobacterium tuberculosis have been developed [5, 6] .
TMPK is found in all organisms requiring de novo pyrimidine synthesis, and crystal structures of the enzyme from a number of different species have been determined [7] [8] [9] [10] [11] . The protein is a homodimer with a subunit fold consisting of a five-stranded parallel β-sheet surrounded by 7-11 α-helices. The nucleotide substrates are bound in a groove on the surface of the subunit, which is characterized by a number of conserved sequence motifs containing structural elements required for substrate recognition and catalysis, namely the so-called 'P-loop' [12] G(X) 4 GKS/T, the critical loop Asp-Arg-Xaa (DRX) motif ( Figure 1a ) and a 'lid' that partially encloses the phosphate donor and is implicated in catalysis [8] . Crystal structures of TMPKs with different combinations of ligands have revealed several conformational states of the protein: an open state in the absence of ligand (where the lid is disordered); a partially closed state in the presence of dTMP (where the lid is disordered in most structures, but ordered in the Mycobacterium tuberculosis enzyme); and a fully closed state in the presence of both co-substrates (where the lid is ordered). Co-crystallization with bi-substrate analogues, such as AP 5 dT [P 1 -(5 -adenosyl)-P 5 -(5 -thymidyl) pentaphosphate], which mimic the ATP-dTMP or ADP-dTDP states [13] has given additional insight into the reaction co-ordinate [14, 15] .
After extensive functional and structural studies on TMPK from several species, a general consensus with regard to the mechanism has been achieved. There is a good overview of the mechanism based primarily on structural and functional studies of the human enzyme [15] . Owing to the complexity of the reaction, there are small differences between species, such as the movement of the P-loop and the lid during catalysis so as to re-orient specific (a) Structure-based amino acid sequence alignment of selected TMPK proteins (Pf, P. falciparum; Hu, human; Sc, Saccharomyces cerevisiae; Mt, Mycobacterium tuberculosis; Ec, E. coli). Strictly conserved residues are coloured red and well-conserved residues are coloured yellow. The locations of the P-loop, critical loop and lid region in the P. falciparum enzyme are highlighted by red triangles, red stars and a blue bar respectively. The secondary structure elements of Pf TMPK are shown above the sequence alignment. This Figure was generated using ESPript [42] . (b) Stereo view of protomer A of Pf TMPK-TMP-ADP (ribbon) showing the dTMP substrate and ADP product as spheres, the P-loop (red), lid region (green), the critical loop (magenta) and the two sodium ions (I and II, grey spheres). The Figures were made with CCP4mg [43] .
basic side chains to stabilize the transition state complex. These may well have impacts on the specificity and relative kinetics of the enzyme. Sequence variation, particularly in the lid region, is associated with structural alterations around the nucleotidebinding site and relocation of catalytic side chains, leading to speculation that the subtleties of the mechanism vary between species [8] . Comparison with related systems has given some general insights into the mechanism. In a similar fashion to adenylate kinase, which has the same overall topology as TMPK, the two nucleotide substrates are believed to bind to the enzyme via a random Bi Bi mechanism [16] . It is agreed that phosphate transfer occurs via an associative, rather than a dissociative, mechanism, such that the migrating phosphate is bound to both substrates in the transition state [17] . The accumulating negative charge on this phosphate in the transition state is proposed to be stabilized by arginine side chains and one or more magnesium ions.
The TMPKs have been classified into two groups [8] . Type I enzymes, which include the human, yeast and Plasmodium proteins, have a basic residue in addition to the lysine residue in the P-loop [Arg 18 in Pf TMPK (P. falciparum TMPK)]. Type II enzymes, including that from Escherichia coli, lack this basic residue in the P-loop; a basic residue from the lid appears to exert a similar function. TMPKs from different species have varying AZT-MP (AZT monophosphate) phosphorylation efficiencies and comparative structural and biochemical studies have shown the structural basis for proficient phosphorylation. TMPKs from E. coli and various viruses are able to phosphorylate AZT-MP very much more efficiently than the human enzyme [18] . The reason for this appears to be the displacement of a catalytically important arginine side chain on the P-loop of the human enzyme in response to AZT-MP binding. In contrast the E. coli enzyme, where the P-loop arginine residue is absent, can accommodate AZT-MP without seriously affecting its catalytic properties [8] . The focus of the present study was to explore the potential of Pf TMPK as an anti-malarial drug target. We present a kinetic analysis of Pf TMPK in combination with the crystal structure of four ligand complexes: dTMP-ADP, AZT-MP-ADP, AP 5 dT and dGMP-ADP. The latter structure provides a structural rationalization for the broader specificity of the Plasmodium enzyme. Two recent studies by Kitade and colleagues present results on the expression and kinetics [19] and on the ligand binding, modelling and mutagenesis [20] of Pf TMPK, and together with new kinetic data they interpreted in terms of the crystal structures presented in the present paper. The present results confirm that the enzyme has structural and catalytic properties distinct from other members of the family, confirming that it is a good candidate for selective inhibition and rational drug design.
EXPERIMENTAL

Materials
AZT-MP, 3 -dGMP and AP 5 dT were purchased from Jena Biosciences. Other nucleotides, including ATP (magnesium salt), were purchased from Sigma-Aldrich. Oligonucleotides were synthesized at the Analytical Services of the López-Neyra Institute of Parasitology and Biomedicine. P. falciparum strain 3D7 was provided by J. M. Bautista of the University Complutense of Madrid, Madrid, Spain. Human erythrocytes and frozen serum were obtained from Centro Regional de Transfusión Sanguínea-SAS (Granada, Spain).
Parasite culture
P. falciparum strain 3D7 was cultured by the method of Trager and Jensen [21] with minor modifications. Cultures were maintained in fresh group-O-positive human erythrocytes suspended at 5 % (v/v) haematocrit in RPMI 1640 (Gibco BRL) containing 10 % (v/v) human serum, and 3 g of glucose, 45 μg of hypoxanthine and 50 μg of gentamicin per litre. The medium was changed daily, as described previously [21] .
Expression of Pf TMPK in E. coli DNA encoding full-length Pf TMPK (633 bp) was amplified by RT (reverse transcription)-PCR from total RNA obtained by standard procedures from parasites released from infected erythrocytes by saponin lysis [22] . The primer TKEcoRI (5 -GGAATTCTTATGACCACAAAAAATTAA-3 ) was used to synthesize the corresponding tmpk cDNA, in the RT reaction, and TKNdeI (5 -GCATATGACTGATGATAAAAAAAA-3 ) and TKEcoRI were used in a second PCR step to amplify the full coding sequence with NdeI and EcoRI restriction sites placed at the 5 -and 3 -ends respectively for cloning into the plasmid vector pET28a (Novagen) so as to append a His 6 -affinity purification tag and a thrombin cleavage site to the N-terminus of the Pf TMPK peptide sequence. The resulting pET-Pf TMPK plasmid was used to transform the E. coli strain BL21 (DE3) and Pf TMPK expression was induced by adding 1 mM isopropyl β-D-thiogalactoside (Roche) and incubating for 4 h at 37
• C or by means of auto-induction [23] for a period of 20 h. The cultures were collected by centrifugation (6600 g for 10 min) and frozen at − 80
• C until use.
Purification of recombinant Pf TMPK
For purification of Pf TMPK, cell pellets were resuspended in 10 ml of binding buffer [50 mM Tris/HCl, pH 7.5, containing 300 mM NaCl, 10 mM imidazole, 1 mM DTT (dithiothreitol) and protease inhibitor cocktail (Pefabloc SC; Roche)] to a give final concentration of 2 mM. Pefabloc SC-protector solution (Roche) was also added to prevent non-specific covalent attachment of the protease inhibitor to the protein (a problem encountered during initial purification trials 
Activity assays
Recombinant Pf TMPK enzyme activity was assayed using a spectrophotometric method by coupling the formation of ADP to the oxidation of NADH in reactions catalysed by pyruvate kinase and lactate dehydrogenase [25] . Assays for inhibition determination were performed in a final volume of 1 ml and a standard assay contained 50 mM Tris/HCl, pH 7. 
is the Michaelis-Menten constant for dTMP and [S] is the concentration of dTMP used in the reaction (50 μM).
Crystallization, data collection and data processing
To remove the His 6 -tag from the protein prior to crystallization, biotinylated thrombin (Novagen) was added to a solution containing 1 mg · ml −1 Pf TMPK in 50 mM Tris/HCl, pH 8.5, 200 mM NaCl and 2.5 mM CaCl 2 (1 unit of thrombin per μg of protein). This solution was gently swirled at room temperature (22 • C) for 24 h. The thrombin was then removed from the reaction mix by immobilization on streptavidinagarose according to the manufacturer's instructions, and a final nickel-affinity chromatography step was used to remove any uncleaved Pf TMPK. Electrospray MS analysis confirmed the identity and purity of the product and the presence of a Gly-Ser-His extension at the N-terminus of the protein (24.973 kDa). Needle-shaped crystals (up to 50 × 50 × 400 μm in size) of four different nucleotide complexes of Pf TMPK were obtained using hanging-drop vapour diffusion, with a 1:1 mixture of protein solution and reservoir solution in the drop (see Supplementary Table S1 available at http://www.BiochemJ. org/bj/428/bj4280499add.htm). Prior to data collection, the crystals were vitrified at 120 K in an appropriate cryoprotectant solution (Supplementary Table S1 ). X-ray data sets for the four protein complexes (see Table 3 ) collected at the ESRF (European Synchrotron Radiation Facility) in Grenoble, were processed using DENZO and SCALEPACK [26] . Initial data on the dGMP complex were collected on the ID24 microfocus beam line at the Diamond Light Source (Didcot, U.K.) from a crystal conglomerate using an 8 × 8 μm beam to hunt for a single lattice with the help of Gwyndaf Evans, Robin Owen and Danny Axford. This led to a 70 % complete data set at 2.7 Å resolution and allowed the presence of the ligand to be confirmed. Subsequent optimization led to larger crystals from which complete data were [19] . 
Structure solution and refinement
The structure of Pf TMPK complexed with dTMP and ADP was solved by molecular replacement with the program PHASER [27] using hTMPK (human TMPK; PDB code 1E2Q) as a search model (the two proteins share 39 % sequence identity). Searches, carried out in two possible space groups (P 3 1 2 1 and P 3 2 2 1), yielded solutions in space group P 3 1 2 1 only and established the presence of three molecules per asymmetric unit. Refinement was carried out in the CCP4 suite of programs [28] using maximum likelihood methods implemented in REFMAC [29] ; 5 % of the data were excluded for R-free calculations. The models were manually rebuilt using the program COOT [30] in conjunction with a 3-fold averaged 2F o -F c electron density map and a F o -F c electron density map. After several rounds of refinement and model building, the dTMP and ADP molecules were built into the electron density in the averaged map. Towards the end of the refinement small differences between the three molecules were modelled into a non-averaged 2F o -F c electron density map and two metal ions were located in each of the three molecules. The other three protein complexes were refined starting from the dTMP-ADP complex without its solvent and ligands, and rebuilt in a similar manner. Dictionaries for the nucleotide ligands were made using PRODRG [31] . Refinement statistics and structural information are listed in Table 3 .
RESULTS AND DISCUSSION
Kinetic parameters and inhibition of Pf TMPK
Standard procedures were used to determine the kinetic parameters of recombinant Pf TMPK. Plots of specific activity against substrate concentration gave typical Michaelis-Menten hyperbolic saturation curves. Kinetic constants were determined for a number of different substrates used as phosphoacceptors (Table 1) . ATP was used as a phosphate donor in the assays, because it was the preferred donor among those tested (results not shown). The phosphorylating efficiency (k cat /K m ) of Pf TMPK was highest for dTMP followed by dGMP, 5FdUMP (5-fluoro-2 -UMP), dUMP, dIMP and GMP. In addition, the K m for ATP was 78.6 μM. This value was obtained at 200 μM dTMP and constant free Mg 2+ concentrations (5 mM). These results are in general agreement with those reported previously [19] , with the relative activities having the same rank order although the two assays differ in the absolute measured values. Although the assay methodology used in both cases is similar, subtle differences may be due to the different expression systems employed or minor differences in the reaction conditions. It is of particular note that the activity is almost as high for the purine dGMP as it is for dTMP. Surprisingly, phosphorylation of the nucleotide analogue AZT-MP was also highly efficient with a k cat /K m close to half that for dTMP. This latter value for AZT-MP is 200-fold higher than the corresponding value for hTMPK and similar to that of the E. coli enzyme (Table 2) .
There was no measurable phosphorylation of the nucleosides uridine, thymidine, deoxyuridine and AZT by Pf TMPK. Likewise, purine derivatives such as ganciclovir {9-[(1,3-dihydroxy-2-propoxy) methyl] guanine} and 3 -deoxyguanosine-5 -monophosphate were not substrates. Different nucleotides and nucleosides were tested as inhibitors of dTMP phosphorylation. 5-fluoro-2 -deoxyuridine and 3 -deoxyguanosine-5 -monophosphate showed K i values of 1.6 mM and 0.25 mM respectively, whereas no inhibition was observed with deoxyuridine, 5-fluoro-5 -deoxyuridine or ganciclovir. The K i for AP 5 dT, a bi-substrate inhibitor of several TMPKs [13] was measured by determining the percentage of inhibition at different inhibitor concentrations and assuming competitive inhibition, giving a value of 0.31 μM. The key findings of the kinetic studies are the high activity of Pf TMPK on AZT-MP and confirmation of its activity on dGMP. These activities will be discussed in terms of the structural investigations below.
Three-dimensional structure
Pf TMPK is a homodimeric protein containing 210 amino acid residues per subunit. All four nucleotide complexes crystallized in space group P 3 1 2 1 with three protomers per asymmetric unit, equating to one crystallographically independent dimer, plus a second dimer lying on a crystallographic two-fold axis. We first give a generic description of those features which are common to all four complexes, before describing the structures in detail in the subsequent sections.
The three protomers are essentially identical to one another, with rmsds (root mean square positional deviations) following superposition of all C α atoms of ∼ 0.25 Å (1 Å = 0.1 nm). Each subunit has a globular structure consisting of a fivestranded parallel β-sheet (β2-β3-β1-β4-β5) surrounded by eight α-helices (Figure 1b) . Interaction with the partner subunit in the dimer occurs predominantly through hydrophobic interactions between α-helices 2, 3 and 5 from each subunit (results not shown). The molecules are well-ordered, with only some small loop and chain termini disorder. Superposition of protomer A from all four complexes shows the backbone conformation to be very similar (Supplementary Figure S1 available at http://www.BiochemJ.org/bj/428/bj4280499add.htm) and corresponds to the closed form of the enzyme, as expected for complexes with both nucleotides.
In the dTMP-ADP, AP 5 dT and dGMP complexes, there are two peaks at essentially identical positions in the electron density maps adjacent to the terminal phosphate groups of the nucleotides, whose shape and co-ordination indicated the presence of two metal ions. These were initially introduced as magnesium ions as magnesium had been included in the crystallization solutions.
However, following refinement, it became clear from the metalligand bond distances (2.3-2.6 Å) that the ions were in fact sodium. The metal sites are shown for the dTMP-ADP complex in Figures 1(b) and 2(c) . The two ions, designated sodium ion (I) and sodium ion (II), are situated 7.0 Å apart with well-defined and independent co-ordination spheres. In retrospect, this is not surprising as although 25 mM magnesium chloride was present in the crystallization drops, sodium is also present at large excess, ∼ 1-2 M. These sodium ions in Pf TMPK, primarily due to their larger ionic radius, occupy somewhat different positions to those observed for the 'biological' magnesium ions seen in the human enzyme (Figure 2c) , and some other known structures, which correspond to the two metal ions essential for phospho group transfer. Equivalent sodium ions are likely to be present, but were not modelled, in the lower resolution AZT-MP complex. The sodium ions have rather different co-ordination from the magnesium ions, as described in the next section, with bonds formed to the nucleotides and protein residues. Pf TMPK has the same general fold and mode of substrate binding as other TMPKs with known structures (see http://www.ebi.ac.uk), suggesting a common mode of action. Thus Pf TMPK would be expected to bind the two nucleotide co-substrates independently of one another, with binding accompanied by stepwise closure of the P-loop and lid so that phosphate transfer can be facilitated by magnesium ions, arginine residue side chains and other essential conserved residues.
A superposition of the dTMP-ADP complex of Pf TMPK on the equivalent complex of the human enzyme shows that the cores of the molecules are very similar (see below), with some minor differences evident in the loops remote from the active site, and some significant deviations in the loops close to the active site (Supplementary Figure S2 available at http://www.BiochemJ.org/bj/428/bj4280499add.htm). A set of substates of the closed form of the human enzyme, with the lid and P-loop being either in the open, half-closed or closed form, depending on the ligand bound, have been described [15] .
Comparison of the backbone conformation of Pf TMPK with that of the human enzyme complexes shows that it corresponds most closely to the closed sub-conformation of the lid and P-loop (Supplementary Figure S3 available at http://www.BiochemJ.org/bj/428/bj4280499add.htm). Indeed in terms of the 'degree of closure', Pf TMPK appears to be even more tightly closed around the nucleotides in the four complexes than in the equivalent human structures. In summary, the comparison of Pf TMPK and hTMPK reveals significant and consistent conformational changes in the catalytically important P-loop and lid regions. These conformational differences, together with natural side-chain variations, may account for differences in specificity and rate in the two enzymes.
Pf TMPK-dTMP-ADP complex
The structure of the Pf TMPK-dTMP-ADP complex was refined at a resolution of 1.9 Å. A prominent groove on the surface of each subunit forms the binding site for dTMP and the preferred phosphate donor, ATP, which bind co-linearly to facilitate phosphate group transfer. Residues of the lid region flank the bound nucleotides, partially enclosing the binding site. The presence of both dTMP (substrate) and ADP (product) results, as stated above, in the closed form of the enzyme with the lid fully ordered. The dTMP is buried, the thymine base (Figure 2c ). The phosphate group makes direct interactions with the side chain of Arg 99 and sodium ion (I), which is penta-co-ordinate, its ligands consisting of a phosphate oxygen (from dTMP), the side-chain oxygen atoms of Asp 17 and Glu 154 and two water molecules (Figure 2c ). The existence of a third highly mobile water molecule to complete the octahedral co-ordination sphere cannot be excluded. Arg 99 , which forms part of the highly conserved critical loop, is the only residue in the structure whose main-chain bond angles lie in a disallowed region of the Ramachandran plot. This phenomenon has been observed in other TMPKs, and can be presumed to be associated with catalysis as steric strain in well-refined crystal structures correlates with functional significance [32] . The residues involved in dTMP binding are highly conserved and superposition of the dTMP-bound TMPK structures available from the PDB shows that the mode of binding is very similar in each.
The ADP, bound close to the surface of the protein, is protected by the lid and is secured in position by a number of interactions (Figure 2b ). These include stacking between the adenine base and the guanidine moiety of Arg 145 , a hydrogen bond between the base and the main-chain oxygen of Arg 182 , three hydrogen bonds between the phosphate groups and the atoms of residues Lys 21 , Ser 22 and Thr 23 (P-loop), and a direct interaction with sodium ion (II). Sodium ion (II) has an octahedral co-ordination sphere comprising one phosphate oxygen from ADP, the sidechain carboxylate of Asp 98 , the side-chain oxygen atom of Ser 19 and three water molecules. The catalytically important Asp 17 of the P-loop has a full complement of polar interactions, including hydrogen bonds to Tyr 107 and Gln 159 . The side chain of the adjacent Arg 18 points away from the substrate, hydrogen bonding to the side chain of Glu 154 . Superposition of the structure of Pf TMPK-dTMP-ADP with the equivalent complex of hTMPK (PDB code 1E2D; sequence identity 40 %; sequence similarity 60 %) shows a highly conserved topology (rmsd of 1.35 Å over 195 C α atoms) and mode of nucleotide binding (Supplementary Figure S2) ; the dTMP-binding sites are essentially identical. However, there are small but significant differences in the lid regions, which differ in conformation, and in the P-loops, which have a relative displacement of 2.1-2.5 Å on main chain atoms, and also differences in side-chain conformations. For the human enzyme, the P-loop displacement results in a shift in position of the phosphate groups of ADP and a different mode of metal binding reflecting the presence of sodium ions rather than magnesium ions (Figure 2c) . The different conformation for Asp 15 results in magnesium ion (I) in hTMPK having a quite different co-ordination sphere, consisting of six water molecules and an indirect rather than direct interaction with dTMP, compared with that of sodium ion (I) in Pf TMPK (Figure 2c) . A probable reason for the difference in the position of the P-loop is a natural variation in the substrate-binding site, Phe 105 (human)→Tyr 107 (Plasmodium). The tyrosine side chain of Pf TMPK forms a hydrogen bond (2.6 Å) with the side chain of Asp 17 , which helps to tether this catalytically important residue in close proximity to the terminal phosphate groups of the nucleotide co-substrates (Supplementary Figure S4 available at http://www.BiochemJ.org/bj/428/bj4280499add.htm). The phenylalanine residue in the human enzyme lacks the capacity to do this. There is a tyrosine at this position in yeast TMPK and this residue has been cited as the reason for its enhanced catalytic activity relative to hTMPK [33] . The other P-loop side chain believed to be important for catalysis, Arg 18 (Arg 16 in hTMPK), is directed away from the nucleotide-binding site in Pf TMPK and hTMPK, in both structures making hydrogen bonding interactions with lid residues. Residue Lys 37 in yeast TPMK corresponds to Arg 41 and Tyr 43 in the human and P. falciparum enzymes respectively (Figure 1a) . These natural variations in the substratebinding site may provide scope for the design of selective inhibitors against Pf TMPK.
Structural basis for dGMP phosphorylation
In view of the kinetic observation that Pf TMPK phosphorylates dGMP with a k cat /K m value close to that for dTMP, we determined the structure of the dGMP-ADP complex, which was refined to a resolution of 2.4 Å. Two sodium ions were modelled at equivalent positions to those in the dTMP complex, but with reduced electron densities reflecting the lower resolution of the analysis. The purine nucleotide is accommodated in the pyrimidine-binding pocket (Figure 3a) with negligible changes in the protein structure compared with the dTMP-ADP structure (rmsd of 0.25 Å over 209 C α atoms). The guanine base is co-planar with the dTMP thymine and just requires the displacement of a single highly ordered water molecule, which in the dTMP-ADP complex hydrogen bonds to the second oxygen atom of thymine and the hydroxy groups of residues Tyr 153 and Ser 108 . The ribose and the phosphate groups of dGMP have closely similar conformations and positions to those of dTMP and the ADP-binding sites are essentially identical.
The structure of the human dTMP-ADP complex is superimposed on the Pf TMPK complex in Figure 3(a) . From the close similarity of the two structures, it might be expected that the human enzyme would also bind dGMP. However, in spite of the fact that the dTMP-binding site of hTMPK is very similar to that of Pf TMPK, particularly around the pyrimidinebinding pocket, several studies have demonstrated that dGMP is not a substrate for the human enzyme [34] [35] [36] . In human cells it appears that a guanylate kinase very efficiently phosphorylates dGMP and GMP [36] . A survey of the P. falciparum genome (see http://www.PlasmoDB.org) shows the existence of a guanylate kinase and a UMP-CMP kinase which have potential functions in dGMP phosphorylation, as guanylate kinases are capable of dGMP phosphorylation [37] , likewise certain UMP kinases, such as that from yeast, have been shown to phosphorylate dGMP [38] . A recent study has revealed that the P. falciparum guanylate kinase utilizes dGMP with very low specificity, which is of interest in respect to the potential contribution of Pf TMPK to cellular dGDP formation and purine nucleotide metabolism in the parasite [39] .
Site-directed mutagenesis has been used previously to evaluate the contributions of selected residues to substrate-binding and catalysis [20] . The mutation of the conserved Phe 74 , whose side chain stacks with the thymine base, to an alanine residue eliminated activity almost entirely. Introduction of individual point mutations between the human and parasite enzymes (Figure 1a) into Pf TMPK (S108T, Y43R and Y43L) had negligible effects on activity. The structure of Pf TMPK reveals that although these residues are close to the active site, they are not directly involved in nucleotide binding. Replacement of Ala 111 by a lysine residue, resulted in a dramatic reduction in the activity of Pf TMPK, especially in dGMP phosphorylation. Ala 111 resides on a seven-residue loop on the outside of the molecule, which has quite different conformations in the two enzymes. As a result, Ala 111 and Lys 109 , rather than coinciding, are displaced by 3.7 Å from one another (C α ), and located 10-12 Å away from the dTMP ligand exerting no direct influence on binding. Indeed the A111K mutation in Pf TMPK would be expected to cause a steric clash with the side chain of Tyr 153 , which is in van der Waals' contact with both the base and the sugar of dTMP. Displacement of the tyrosine side chain would be predicted to affect substrate binding, and this would be exacerbated for the larger dGMP, in keeping with the kinetic results.
Vaccinia virus TMPK is also capable of phosphorylating purine nucleotides [34] and recent structural analysis has revealed a dimer arrangement that is orthogonal, and not anti-parallel, as in other TMPKs. This unusual subunit tilting is closely correlated with enzyme stability and with the presence of a cavity allowing broader substrate specificity [40] . Apart from Plasmodium and vaccinia TMPKs, the only other kinase that is known to handle both dGMP and dTMP is the bacteriophage T4 deoxynucleotide kinase. The structure of the phage enzyme is similar to the fold of the NMP kinases, but with a different dimerization mode and no apparent conservation of the active-site residues [41] .
Pf TMPK-AP 5 dT complex
The bisubstrate inhibitor AP 5 dT [13] has been co-crystallized with TMPK from a number of species [6, 14, 15] . In the Pf TMPK complex, AP 5 dT is bound at full occupancy with the same mode of binding in all three protomers (Figure 3b) . The five phosphate groups of the inhibitor are labelled PA-PE, phosphate PA being closest to the thymidine group. Superposition with the Pf TMPK-TMP-ADP complex shows that the effect of bisubstrate binding on the protein conformation is minimal, with an rmsd for all mainchain atoms of 0.3 Å. The adenosine and thymidine moieties of AP 5 dT superpose closely with the nucleoside species of ADP and dTMP, as do the phosphates PA, PD and PE with the phosphate of dTMP and the β-and α-phosphates of ADP respectively. The two bridging phosphate groups of AP 5 dT, PB and PC, are bound next to the P-loop, flanked by the two sodium ions. The non-bridging oxygens of all five phosphate groups make polar interactions with Lys 21 hydrogen bonds to a phosphate oxygen of PC. The presence of this interaction is consistent with a role for Arg 18 in transitionstate stabilization, as has been shown for the yeast and human enzymes. Two sodium ions were modelled in the structure, and lie approx. 0.7 Å from the equivalent ions in the dTMP-ADP complex.
Superposition of Pf TMPK-AP 5 dT with the equivalent complexes from other species (Figure 3b) confirms that the inhibitors bind in the same place, although only the thymidine moieties are truly co-incident. The atoms of the five phosphate groups and the adenosine moieties are displaced by 0.3-1.2 Å (one of the phosphates is ordered in the human complex). The sodium ion (I) and magnesium ion (I) lie 2.1 Å apart in the human and Plasmodium enzymes, although they carry out the same role, co-ordinating to two oxygen atoms of phosphates PC and PD. The P-loops of the two structures overlay more closely than they do in the dTMP-ADP complex, although there are still mainchain atom differences of 0. 5 dT clearly varies in detail between species, but is in keeping with the accepted mechanism of the enzyme.
Pf TMPK efficiently phosphorylates AZT-MP
Another characteristic of Pf TMPK highlighted by the present kinetic studies is its ability to phosphorylate AZT-MP 200-fold more efficiently than hTMPK ( Table 2 ). The conversion of AZT-MP into AZT-DP (AZT diphosphate) by the human enzyme is a crucial step in the production of the active drug AZT-TP (AZT triphosphate) in antiviral therapy. The antiviral effect of the drug is achieved by its inhibition of nascent DNA chain growth during replication following its acceptance as a substrate by the viral DNA polymerase [8] .
Analysis of the PfTMPK-AZT-MP-ADP complex shows that both nucleotide substrates are at full occupancy in each protomer in the asymmetric unit, however only in molecule A can the position of the azide group be defined with confidence ( Figure 3c ). The absence of electron density for azide in the other two protomers may reflect inherent disorder and is exacerbated by the modest (3.0 Å) resolution. The AZT-MP azide moiety in molecule A is accommodated in a cavity surrounded by the side chains of Asp 17 , Leu 59 , Glu 151 and Glu 154 (Figure 3d ). It causes a small reorientation of the dTMP phosphate group and minor conformational changes in the side chains of Glu 154 and Asp 17 , the latter retaining its hydrogen bond to the side chain of Tyr 107 . Owing to the limited resolution, metal ions were not modelled in this complex ( Table 3 ). The structure superimposes very closely on the dTMP-ADP complex (rmsd of 0.27 Å over 208 C α atoms) and the positions of the two sets of nucleotide ligands are essentially identical.
Comparison with the structure of the equivalent human enzyme complex (PDB entry 1E99) shows differences in the P-loop organization similar to those observed in the equivalent dTMP-ADP comparisons. The close proximity of the side chain of Asp 17 to the AZT-MP in Pf TMPK causes a reorientation of the azide group relative to that in the human complex. This reorientation does not appear to affect the availability of Asp 17 for catalysis. Indeed, given that it is likely that no further P-loop changes are required for transition-state formation in the P. falciparum enzyme (compared with the structure of Pf TMPK-AP 5 dT) it would appear to have a mechanistic advantage over the human enzyme, in which P-loop movements toward the transition state would result in a steric clash with the azide group of AZT-MP. These structural observations provide a likely explanation for the higher activity of Pf TMPK relative to hTMPK towards AZT-MP (Table 2) .
Poor AZT-MP phosphorylation in the type I TMPKs, such as the yeast and human enzymes, which contain a basic residue in the P-loop has been proposed to be due to the azido moiety in AZT-MP disrupting an important bidentate interaction between the 3 hydroxy group of TMP and the conserved P-loop carboxylic acid which results in a displacement of the P-loop [8] . This is in contrast with type II TMPKs, such as the E. coli enzyme, where the analogous interaction with the P-loop carboxylic acid residue is side-on, permitting small conformational changes to accommodate the azido group of AZT-MP without affecting significantly the position of the P-loop. It has been proposed that the P-loop could influence the phospho transfer rate of type I TMPKs in different ways [11] . First, by shifting the position of ATP relative to the acceptor, catalysis would be impaired.
Secondly, movement of the P-loop upon binding of AZT-MP would result in the mis-positioning of P-loop arginine involved in catalysis (Arg 18 in Pf TMPK). Thirdly, mis-positioning of the P-loop carboxylic acid residue, a strictly conserved amino acid within the TMPK family, may hinder catalysis [18] . The steric clash between the azide group and the P-loop as the latter closes over the substrate is not likely to occur in Pf TMPK as hydrogen bonding between Asp 17 and Tyr 107 places the P-loop in the fully closed position at an earlier stage in the reaction, causing the azide group to adopt a different orientation (Figure 3c ), which should not interfere with catalysis. This significance of this tyrosine residue for AZT-MP activation is supported by kinetic results on the hTMPK-F105Y mutant [18, 33] which is much more tolerant of AZT-MP than the wild-type enzyme ( Table 2) .
In summary, despite the overall conservation of sequence and structure in the nucleotide-binding site of human and P. falciparum TMPK, it is apparent that there are a number of subtle but seemingly significant differences in the substrate and inhibitor specificities. These are highlighted by differences in the reaction catalysed by the two enzymes with dGMP and AZT-MP, evidence to suggest that Pf TMPK may indeed be exploited as a target for anti-malarial drug discovery.
